Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.45	6.21	20.75	44.58	69.72	66.84
Short-Term Investments	19.84	34.57	54.31	45.6	37.08	66.98
Cash & Short-Term Investments	26.29	40.78	75.06	90.18	106.8	133.82
Cash Growth	-45.06%	-45.66%	-16.77%	-15.56%	-20.19%	34.00%
Other Receivables	1	0.88	0.99	1	1.13	-
Receivables	1	0.88	0.99	1	1.13	-
Prepaid Expenses	1.07	0.99	1.17	1.2	1.48	1.24
Other Current Assets	0.85	1.38	0.21	1.36	2.27	2.8
Total Current Assets	29.2	44.04	77.44	93.75	111.67	137.86
Property, Plant & Equipment	1.1	0.81	0.62	0.68	1.43	1.1
Long-Term Investments	0.08	0.08	0.08	3.58	19.93	50.46
Goodwill	-	-	17.63	-	-	-
Other Intangible Assets	0.46	60.05	63.67	5.9	-	-
Other Long-Term Assets	11.8	9.51	8.47	-	0.19	0.04
Total Assets	109.9	114.48	167.9	103.91	133.23	189.47
Accounts Payable	3.4	2.9	2.03	0.57	4.91	3.56
Accrued Expenses	4.71	3.97	3.12	1.86	8.39	13.16
Current Portion of Leases	0.11	0.1	0.06	0.45	0.74	0.24
Other Current Liabilities	0.3	0.31	4.36	0.19	0.18	0.04
Total Current Liabilities	26.04	7.28	9.57	3.07	14.22	17
Long-Term Debt	-	14.32	13.43	-	-	-
Long-Term Leases	0.36	0.39	0.32	-	0.42	0.21
Long-Term Deferred Tax Liabilities	5.59	4.96	5.3	0.25	-	-
Other Long-Term Liabilities	76.84	57.38	54.19	-	-	-
Total Liabilities	108.84	84.33	82.82	3.32	14.64	17.2
Common Stock	0.05	0.04	0.04	0.04	0.03	0.03
Additional Paid-In Capital	415.71	406.61	401.64	389.11	355.23	318.57
Retained Earnings	-420.99	-376.47	-319.64	-288.26	-236.6	-146.65
Comprehensive Income & Other	6.29	-0.04	3.05	-0.29	-0.08	0.31
Total Common Equity	1.06	30.15	85.08	100.59	118.59	172.26
Shareholders' Equity	1.06	30.15	85.08	100.59	118.59	172.26
Total Liabilities & Equity	109.9	114.48	167.9	103.91	133.23	189.47
Total Debt	17.99	14.81	13.81	0.45	1.16	0.45
Net Cash (Debt)	8.3	25.97	61.25	89.73	105.64	133.37
Net Cash Growth	-74.40%	-57.59%	-31.74%	-15.06%	-20.79%	33.56%
Net Cash Per Share	0.18	0.60	1.64	2.68	3.55	4.57
Filing Date Shares Outstanding	55.68	44	43.22	36.28	30.15	29.55
Total Common Shares Outstanding	54.49	44	42.97	36.14	30.07	29.54
Working Capital	3.16	36.76	67.87	90.68	97.45	120.87
Book Value Per Share	0.02	0.69	1.98	2.78	3.94	5.83
Tangible Book Value	0.6	-29.9	3.79	94.69	118.59	172.26
Tangible Book Value Per Share	0.01	-0.68	0.09	2.62	3.94	5.83
Machinery	1.35	0.89	0.68	0.43	0.61	0.46
Leasehold Improvements	0.04	0.03	0.04	0.02	0.06	0.02

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q